Online ISSN: 2515-8260

Putting the “bio” in “biotherapeutics”/checkpoints for biosimilars/ application of biosimilars

Main Article Content

Juan V. Esplugues , Bruno Flamion , Lluis Puig


The number of biosimilar medicines on the market is steadily increasing, due, in part, to patent expiration of several top-selling biologic medicines. These three e-learning modules discuss the basic concepts behind biosimilar medicines and highlight key regulatory considerations when using biosimilar medicines in medical practice.

Article Details